PRKAA1 and breast carcinoma: Metformin radiosensitised FSaII mouse fibrosarcoma cells and human breast cancer MCF7 [27], lung cancer cells A549 and H1299 [28, 29] and preferentially killed cancer stem cells, by activating AMPK and suppressing mTOR [27].